Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
在早期有症状的 COVID-19 患者中，莫努匹拉韦与利托那韦增强的尼尔马特雷韦的抗病毒疗效比较（PLATCOV）：一项开放标签、2 期、随机、对照、适应性试验
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(23)00493-0
Schilling, William H K; Jittamala, Podjanee; Watson, James A; Boyd, Simon; Luvira, Viravarn; Siripoon, Tanaya; Ngamprasertchai, Thundon; Batty, Elizabeth M; Cruz, Cintia; Callery, James J; Singh, Shivani; Saroj, Manisaree; Kruabkontho, Varaporn; Ngernseng, Thatsanun; Tanglakmankhong, Nuttakan; Tubprasert, Jaruwan; Abdad, Mohammad Yazid; Madmanee, Wanassanan; Kouhathong, Jindarat; Suwannasin, Kanokon; Pagornrat, Watcharee; Piaraksa, Nattaporn; Hanboonkunupakarn, Pongtorn; Hanboonkunupakarn, Borimas; Poovorawan, Kittiyod; Potaporn, Manus; Srisubat, Attasit; Loharjun, Bootsakorn; Taylor, Walter R J; Chotivanich, Vasin; Chotivanich, Kesinee; Imwong, Mallika; Pukrittayakamee, Sasithon; Dondorp, Arjen M; Day, Nicholas P J; Teixeira, Mauro M; Piyaphanee, Watcharapong; Phumratanaprapin, Weerapong; White, Nicholas J
